Form 8-K - Current report:
SEC Accession No. 0001742924-22-000002
Filing Date
2022-02-17
Accepted
2022-02-17 16:21:20
Documents
14
Period of Report
2022-02-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lthm-20220217.htm   iXBRL 8-K 34788
2 EX-99.1 liventex99112312021.htm EX-99.1 276152
6 liventhrgb1002a09.jpg GRAPHIC 58137
  Complete submission text file 0001742924-22-000002.txt   548986

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lthm-20220217.xsd EX-101.SCH 1920
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lthm-20220217_lab.xml EX-101.LAB 23970
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lthm-20220217_pre.xml EX-101.PRE 12650
8 EXTRACTED XBRL INSTANCE DOCUMENT lthm-20220217_htm.xml XML 11348
Mailing Address 1818 MARKET STREET PHILADELPHIA PA 19103
Business Address 1818 MARKET STREET PHILADELPHIA PA 19103 215-299-5900
Livent Corp. (Filer) CIK: 0001742924 (see all company filings)

EIN.: 824688610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38694 | Film No.: 22648388
SIC: 2800 Chemicals & Allied Products